youtube_live
Q3 2026 earnings • released • EPS miss -10,96% • Revenue beat +2,79%
See resultschevron_right
6472:TPE
Bora Pharmaceuticals Co Ltd
NT$363,00
arrow_downward
-9,70%(-39,00) 1D
16 Nov., 13:30:38 GMT+8 · TWD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 6472...
Open
NT$409,00
High
NT$418,50
Low
NT$363,00
Mkt. cap
46,47 mjd
Avg. vol.
702,79 k
Volume
1,74 m
P/E ratio
29,79
52-wk high
NT$633,00
52-wk low
NT$330,50
EPS
NT$12,19
No. of employees
36
Open
NT$409,00
High
NT$418,50
Low
NT$363,00
Mkt. cap
46,47 mjd
Avg. vol.
702,79 k
Volume
1,74 m
P/E ratio
29,79
52-wk high
NT$633,00
52-wk low
NT$330,50
EPS
NT$12,19
No. of employees
36
News stories
From web sources and news partners
www.marketscreener.com
·
4 uur gelede
Bora Pharmaceuticals : The Company's Board of Director approves the Company's consolidated financial statements for the quarter ended September 30, 2026
About Bora Pharmaceuticals Co Ltd
CEOBobby Sheng
Employees36
Founded2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebora-corp.com